Your browser doesn't support javascript.
loading
Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation.
Terzian, Zaven; Urena, Marina; Himbert, Dominique; Gardy-Verdonk, Constance; Iung, Bernard; Bouleti, Claire; Brochet, Eric; Ghodbane, Walid; Depoix, Jean-Pol; Nataf, Patrick; Vahanian, Alec.
Afiliação
  • Terzian Z; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Urena M; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Himbert D; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France. Electronic address: dominique.himbert@aphp.fr.
  • Gardy-Verdonk C; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Iung B; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Bouleti C; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Brochet E; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Ghodbane W; Cardiac Surgery Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Depoix JP; Anaesthesiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Nataf P; Cardiac Surgery Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
  • Vahanian A; Cardiology Department, DHU FIRE, Bichat Hospital, AP-HP, 75018 Paris, France.
Arch Cardiovasc Dis ; 110(11): 607-615, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28411108
ABSTRACT

BACKGROUND:

The causes of procedural deaths after transcatheter aortic valve implantation (TAVI) have been scarcely detailed.

AIMS:

To assess these causes and their temporal trends since the beginning of the TAVI era.

METHODS:

From October 2006 to April 2014, 601 consecutive high-risk/inoperable patients with severe aortic stenosis underwent TAVI using the Edwards SAPIEN or SAPIEN XT or the Medtronic CoreValve. The transfemoral route was the default approach; the transapical or left subclavian approaches were alternative options. Patients were divided into three tertiles according to the date of the procedure.

RESULTS:

Procedural death occurred in 45 patients (7.5%), with a median±standard deviation age of 83±7 years; 23 were men (51%) and the mean logistic EuroSCORE was 26±16%. The main cause of death was heart failure (n=19, 42%), followed by cardiac rupture (n=12, 27%), intensive care complications (n=9, 20%) and vascular complications (n=5, 11%). The mortality rate was higher after transapical than transfemoral TAVI (17% vs. 5%; P<0.001). The mortality rate decreased over time (11.9% in the first tertile, 6.0% in the second and 4.5% in the third [P=0.007]), driven by a reduction in heart failure-related deaths (6.5% in the first tertile vs. 1.5% in the third; P=0.011). Vascular complication-related deaths disappeared in the third tertile. However, there was no decrease in deaths related to cardiac ruptures and intensive care complications.

CONCLUSIONS:

The procedural mortality rate of TAVI decreased over time, driven by the decrease in heart failure-related deaths. However, efforts should continue to prevent cardiac ruptures and improve the outcomes of patients requiring intensive care after TAVI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Substituição da Valva Aórtica Transcateter / Insuficiência Cardíaca Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Substituição da Valva Aórtica Transcateter / Insuficiência Cardíaca Idioma: En Ano de publicação: 2017 Tipo de documento: Article